Outstanding report - with significant progress!
Highlights:
1. Significant advances have been made in the fundamental design and engineering based on our trial.
2. Algorithms have made substantial progress from our learnings in the hospital
3. Algorithms are being coded to medical device requirements by our in-house EMVision team
4. Further patient datasets will allow continued improvements to localisation & classification of strokes
5. Our technology continues to see strong support from stroke experts in these hospitals
6. We are pursuing an application for the Breakthrough Device Designation program.
7.Under the AASA program, EMV’s portable Brain Scanner offers a potentially game-changing solution
8. Opportunity to deliver substantial savings to hospitals/healthcare system well beyond the cost of the product over its lifetime
9. Keysight Technologies collaboration continues to progress exceptionally well
10. Global medical imaging and device manufacturers have shown significant interest in our novel technology and its potential range of applications
11. Interactions have been with some of the most senior executives and decision makers at these companies
12. Our international visibility increasing
- Forums
- ASX - By Stock
- EMV
- Ann: Half Year Report & CEO Update
Ann: Half Year Report & CEO Update, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.00 |
Change
0.000(0.00%) |
Mkt cap ! $171.0M |
Open | High | Low | Value | Volume |
$2.00 | $2.05 | $1.99 | $107.6K | 53.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2710 | $1.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.06 | 2346 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2710 | 1.985 |
1 | 1500 | 1.980 |
1 | 5000 | 1.970 |
1 | 1000 | 1.960 |
4 | 17500 | 1.950 |
Price($) | Vol. | No. |
---|---|---|
2.060 | 2346 | 1 |
2.200 | 2384 | 3 |
2.220 | 18000 | 1 |
2.240 | 1888 | 2 |
2.250 | 7000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online